학술논문

Targeting of the CD161 inhibitory receptor enhances T-cell–mediated immunity against hematological malignancies
Document Type
Article
Source
In Blood 21 March 2024 143(12):1124-1138
Subject
Immunobiology and Immunotherapy
Lymphoid Neoplasia
Language
ISSN
0006-4971